Categories: News

Fortis surges on nod for stake buy

New Delhi, July 14, 2018: Shares of Fortis Healthcare rose by 4 per cent after its board approved a T4,000 – crore offer from Malaysia’s IHH Healthcare for 31.1 per cent stake in the healthcare company. The stock jumped 3.97 per cent to close at T147.8 on the BSE. Intraday, it soared 5.1 per cent to T149.4. The company’s market valuation rose by T293.13 crore to 77,666.13 crore. In terms of volume, 16.35 lakh shares of the company were traded on the BSE and over two crore shares changed hands on the NSE during the day.

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

8 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago